Degussa's New China L-Methionine Plant Completed Successfully

09-Dec-2004
The new Degussa L-methionine plant was officially inaugurated at the Nanning Only-Time Rexim Pharmaceutical Co., Ltd. (NOTR). The plant is situated in Wuming, Nanning City, capital of Guangxi Zhuang Autonomous Region, South China. With the establishment of this plant, Rexim S.A.S., a 100% subsidiary of the Degussa Group, has "confirmed its strong commitment to the infusion solution industry and all other segments of application," said Mr. Manfred Mueller, President of Rexim at the inauguration ceremony. Degussa started the production of L-Methionine in the 1980s in Constance, Germany. After closing of the plant in Constance in 2001, Degussa decided to transfer its technology to Wuming and furthermore increase capacity to 340 tpa. The L-Methionine plant, the world's largest, will cover more than 50% of the world's market demand. NOTR is a joint venture that was founded in 2001 between Nanning Only-Time Pharmaceutical Co., Ltd. and Rexim S.A.S., France. The first phase of the joint venture was to build an amino acids refining unit with a capacity of 500 tpa, which was inaugurated in Nov. 2003. The new L-Methionine plant is the second phase of the joint venture, which increased the total Degussa investment in Wuming to 35 million Euros. The plant, operated by the Exclusive Synthesis & Catalyst Business Unit, represents Degussa's state-of-the-art technology. Running a continuous enzymatic reaction process, the plant will ensure consistency and stability of quality according to Degussa's high standards. "The new L-Methionine plant opens a new chapter in our book of China operations. We are proud that from now on we will be able to deliver the highest quality materials from here in Wuming," said Mr. Eric Baden, President of Degussa China.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!